ATAINASDAQHealthcare · Medical - Pharmaceuticals

Atai Beckley N.V

$4.07+2.71%(+$0.11)

TickerSpark Score

56/100

Mixed

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATAI research report →

52-Week Range45% of range

Low $1.89

Current $4.07

High $6.75

Companywww.ataibeckley.com

Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.

CEO: Srinivas G. Rao
IPO: 2021
Employees: 54
HQ: Amstelveen, NL

Price Chart

+98.23% · this period

Valuation

Market Cap: $1.50B
P/E: -1.39
P/S: 429.60
P/B: 4.64
EV/EBITDA: -2.20
Div Yield: 0.00%

Profitability

Gross Margin: 95.21%
Op Margin: -3553.99%
Net Margin: -19019.44%
ROE: -366.49%
ROIC: -51.60%

Growth & Income

Revenue: $4.09M · 1227.60%
Net Income: $-660,047,000 · -342.19%
EPS: $-2.91 · -212.90%
Op Income: $-113,347,000
FCF YoY: -25.50%

Performance & Tape

52W High: $6.75
52W Low: $1.89
50D MA: $3.95
200D MA: $4.30
Beta: 1.60
Avg Volume: 5.86M

Get TickerSpark's AI analysis on ATAI

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Nov 25, 25	Feilding-Mellen Cosmo	director	other	10,000	$44.80K
Nov 25, 25	Feilding-Mellen Cosmo	director	sell	40,400	$180.99K
Nov 5, 25	HERSHBERG ROBERT	director	other	456,011	$615.61K
Nov 5, 25	HERSHBERG ROBERT	director	other	103,000	$461.44K
Nov 5, 25	HERSHBERG ROBERT	director	other	97,716	$131.92K
Nov 5, 25	HERSHBERG ROBERT	director	other	62,394	$84.23K
Nov 5, 25	Feilding-Mellen Cosmo	director	other	7,702,990	$0
Nov 5, 25	Feilding-Mellen Cosmo	director	other	103,000	$461.44K
Nov 5, 25	Feilding-Mellen Cosmo	director	other	40,400	$180.99K
Nov 4, 25	Braunstein Scott	director	other	56,818	$300.00K

Our ATAI Coverage

View all →

ipo_article

Optimi Health Corp. IPO: What to Know Before It Lists

Optimi Health Corp. (NASDAQ: OPTH) is expected to list on 2026-05-20, with a price range not disclosed and 2,500,000 shares offered. The setup is a small, early commercial psychedelic manufacturer with real revenue, but it is still carrying losses, a working capital deficit, and heavy regulatory dependence.

May 20, 2026